+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polymerase Chain Reaction Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

  • PDF Icon

    Report

  • 190 Pages
  • March 2022
  • Region: Global
  • Transparency Market Research
  • ID: 4851952
This report on the global polymerase chain reaction market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global polymerase chain reaction market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global polymerase chain reaction market from 2021 to 2028.



The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global polymerase chain reaction market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global polymerase chain reaction market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global polymerase chain reaction market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global polymerase chain reaction market.

The report delves into the competition landscape of the global polymerase chain reaction market. Key players operating in the global polymerase chain reaction market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global polymerase chain reaction market profiled in this report.

Key Questions Answered in Global Polymerase Chain Reaction Market Report

  • What will be the revenue generated in the polymerase chain reactions market across all geographies during the forecast period?
  • What are key trends in the global polymerase chain reactions market?
  • What are major drivers, restraints, and opportunities in the market?
  • Which region is set to expand at a high CAGR during the forecast period?
  • Which segment of the global polymerase chain reactions will generate the maximum revenue globally by 2028?
  • Which segment will expand at the maximum CAGR during the forecast period?

Polymerase Chain Reaction Market - Research Objectives and Research Approach

The comprehensive report on the global polymerase chain reaction market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global polymerase chain reaction market in terms of product type, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global polymerase chain reaction market.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global PCR Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global PCR Market Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Product Portfolio Analysis, by Key Players
5.2. Distributor Analysis, by Key Players
5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
5.4. Market Value Share Analysis (%): by PCR Technology
5.5. Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder
6. Global PCR Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2028
6.3.1. Instruments
6.3.1.1. Standard PCR Systems
6.3.1.2. RT PCR Systems
6.3.1.3. Digital PCR Systems
6.3.2. Reagents
6.3.3. Consumables
6.4. Market Attractiveness Analysis, by Product
7. Global PCR Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2028
7.3.1. Pharmaceutical & Biotechnology Industries
7.3.2. Clinical Diagnostics Labs & Hospitals
7.3.3. Academic & Research Organizations
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global PCR Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Rest of the World
8.3. Market Attractiveness Analysis, by Country/Region
9. North America PCR Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017-2028
9.2.1. Instruments
9.2.1.1. Standard PCR Systems
9.2.1.2. RT PCR Systems
9.2.1.3. Digital PCR Systems
9.2.2. Reagents
9.2.3. Consumables
9.3. Market Value Forecast, by End-user, 2017-2028
9.3.1. Pharmaceutical & Biotechnology Industries
9.3.2. Clinical Diagnostics Labs & Hospitals
9.3.3. Academic & Research Organizations
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017-2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. by Product
9.5.2. by End-user
9.5.3. by Country
10. Europe PCR Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2028
10.2.1. Instruments
10.2.1.1. Standard PCR Systems
10.2.1.2. RT PCR Systems
10.2.1.3. Digital PCR Systems
10.2.2. Reagents
10.2.3. Consumables
10.3. Market Value Forecast, by End-user, 2017-2028
10.3.1. Pharmaceutical & Biotechnology Industries
10.3.2. Clinical Diagnostics Labs & Hospitals
10.3.3. Academic & Research Organizations
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. by Product
10.5.2. by End-user
10.5.3. by Country/Sub-region
11. Asia Pacific PCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2028
11.2.1. Instruments
11.2.1.1. Standard PCR Systems
11.2.1.2. RT PCR Systems
11.2.1.3. Digital PCR Systems
11.2.2. Reagents
11.2.3. Consumables
11.3. Market Value Forecast, by End-user, 2017-2028
11.3.1. Pharmaceutical & Biotechnology Industries
11.3.2. Clinical Diagnostics Labs & Hospitals
11.3.3. Academic & Research Organizations
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. by Product
11.5.2. by End-user
11.5.3. by Country/Sub-region
12. Rest of the World PCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2028
12.2.1. Instruments
12.2.1.1. Standard PCR Systems
12.2.1.2. RT PCR Systems
12.2.1.3. Digital PCR Systems
12.2.2. Reagents
12.2.3. Consumables
12.3. Market Value Forecast, by End-user, 2017-2028
12.3.1. Pharmaceutical & Biotechnology Industries
12.3.2. Clinical Diagnostics Labs & Hospitals
12.3.3. Academic & Research Organizations
12.3.4. Others
12.4. Market Attractiveness Analysis
12.4.1. by Product
12.4.2. by End-user
13. Competition Landscape
13.1. Market Player - Competition Matrix Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis by Company (2020)
13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
13.3.1. Bio-Rad Laboratories, Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. QIAGEN N.V.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. F. Hoffmann-La Roche AG
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Thermo Fisher Scientific, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Becton, Dickinson and Company
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Abbott
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Siemens Healthcare GmbH (Siemens AG)
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. BioMérieux SA
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. Danaher Corporation
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. Agilent Technologies
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Abbott
  • Siemens Healthcare GmbH (Siemens AG)
  • BioMérieux SA
  • Danaher Corporation
  • Agilent Technologies